Compare ONB & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ONB | RGEN |
|---|---|---|
| Founded | 1834 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.9B | 8.2B |
| IPO Year | N/A | N/A |
| Metric | ONB | RGEN |
|---|---|---|
| Price | $23.44 | $166.75 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 10 |
| Target Price | $26.09 | ★ $174.90 |
| AVG Volume (30 Days) | ★ 2.9M | 701.7K |
| Earning Date | 01-20-2026 | 10-28-2025 |
| Dividend Yield | ★ 2.40% | N/A |
| EPS Growth | ★ 2.73 | N/A |
| EPS | ★ 1.69 | 0.03 |
| Revenue | ★ $2,110,915,000.00 | $707,890,000.00 |
| Revenue This Year | $45.73 | $17.84 |
| Revenue Next Year | $14.53 | $12.57 |
| P/E Ratio | ★ $13.79 | $6,381.36 |
| Revenue Growth | ★ 20.70 | 11.74 |
| 52 Week Low | $16.83 | $102.97 |
| 52 Week High | $24.49 | $182.52 |
| Indicator | ONB | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 68.06 | 60.24 |
| Support Level | $22.70 | $156.01 |
| Resistance Level | $23.55 | $165.02 |
| Average True Range (ATR) | 0.44 | 4.71 |
| MACD | 0.05 | -0.46 |
| Stochastic Oscillator | 91.34 | 80.61 |
Old National Bancorp with almost $10 billion in assets following its latest acquisition, Old National Bancorp is a financial services bank holding company headquartered in Indiana. Based in Evansville, Ind., Old National owns multiple financial services operations in Indiana, Illinois, and Kentucky. The company provides a group of similar community banking services, including such products and services as commercial, real estate, and consumer loans; deposits; and brokerage, trust, and investment advisory services.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.